The idea may sound like something straight out of science fiction, but it is an extremely rare medical phenomenon that has been documented: Did you know that a woman can become pregnant with a second baby while she is already pregnant?This phenomenon is known as superfetation. It is not simply a typical twin pregnancy, but an unusual biological event in which two fetuses develop in the same uterus despite being conceived at different times and having different gestational ages!In this article on Dalili Medical, we uncover the mysteries behind this fascinating phenomenon and explore how modern medicine explains it.
Superfetation is a rare phenomenon in which a new pregnancy occurs after an existing pregnancy has already begun. In this process, a second egg is fertilized and implants in the uterus while an embryo from an earlier conception is already developing.
This differs significantly from a typical twin pregnancy. In ordinary twin pregnancies, both eggs are generally fertilized during the same menstrual cycle, whereas superfetation involves a noticeable interval—potentially days or weeks—between the first and second fertilization events. This phenomenon is considered extremely rare in humans, and diagnosing it can be particularly challenging because noticeable differences in the size or growth rate of two fetuses may be attributed to other, more common causes.
Although no definitive, established cause of superfetation in humans has been identified, scientists have proposed several possible mechanisms to explain how it might occur:
A Second Ovulation During Pregnancy: Under normal circumstances, the hormonal changes associated with pregnancy—particularly elevated progesterone and estrogen levels—suppress further ovulation. However, some hypotheses suggest that the release of another egg may exceptionally occur.
Hormonal Imbalances: Unusual fluctuations in hormones such as luteinizing hormone (LH), estrogen, and progesterone may theoretically create conditions that allow a second ovulation. However, this mechanism remains hypothetical and has not been conclusively established in humans.
Fertility Medications and Assisted Reproductive Technologies: Some exceptional cases have been discussed in connection with ovarian stimulation medications, such as clomiphene, or assisted reproductive procedures involving overlapping treatment cycles. These circumstances may theoretically create an opportunity for a second conception before the first pregnancy has been confirmed.
Persistence of a Receptive Uterine Lining: Pregnancy causes substantial changes in the uterine lining, making the implantation of another embryo extremely difficult. However, some hypotheses suggest that if these changes have not yet fully developed during the very early stages of pregnancy, implantation of another embryo might theoretically remain possible if ovulation and fertilization occur.
Combined Intrauterine and Ectopic Pregnancies: Extremely rare cases have been reported in which an intrauterine pregnancy coexists with another pregnancy in the fallopian tube, with a suspected difference in timing. Although such cases may raise the possibility of superfetation, different implantation locations alone do not provide definitive evidence that fertilization occurred at different times.
The extreme rarity of superfetation is thought to result from the need to overcome several natural protective mechanisms that normally work together during pregnancy. These include:
Suppression of ovulation: Hormonal changes during pregnancy generally prevent the release of additional eggs.
Changes in the cervix: The formation of cervical mucus during pregnancy makes sperm passage into the upper reproductive tract more difficult.
Changes in the uterine lining: Pregnancy-related changes in the endometrium make the implantation of another embryo highly unlikely.
Consequently, there are currently no reliable indicators or clearly established risk factors that can be used to predict superfetation in humans.
Superfetation is defined as the fertilization and implantation of a new embryo after an earlier pregnancy has already begun. Although there is no universally accepted formal medical classification of human superfetation, suspected cases can be described according to the location of the embryos and the timing of the second fertilization event, as outlined below.
Intrauterine Superfetation: Both fetuses are located within the uterine cavity but are believed to have resulted from fertilization events occurring at different times. This may lead to noticeable differences in their estimated gestational ages and sizes during ultrasound examinations.
Suspected Superfetation Associated With an Ectopic Pregnancy: This possibility may be considered when a normal intrauterine pregnancy is accompanied by another pregnancy outside the uterus, such as in a fallopian tube, with a suspected difference in timing. However, the difference in location alone does not establish superfetation. Such a situation may instead represent a condition known as heterotopic pregnancy, in which an intrauterine and an ectopic pregnancy occur simultaneously.
Superfetation With a Short Time Interval: The second fertilization is thought to occur relatively soon after the first. Clinically, it may be difficult to distinguish this from an ordinary twin pregnancy.
Superfetation With a Longer Time Interval: The interval between the two presumed conception events is greater and may be more apparent, potentially resulting in more noticeable differences in the fetuses' estimated gestational ages and developmental stages.
These categories are descriptive ways of discussing timing and location, not officially recognized medical classifications with standardized time limits.
It is essential to distinguish accurately between these two similar medical terms:
Superfetation: Refers to a new fertilization and implantation event occurring after an earlier pregnancy has already become established and begun developing.
Superfecundation: Refers to the fertilization of two or more eggs during approximately the same ovulatory period. This may occur following a single sexual encounter or multiple encounters during the same ovulatory cycle.
Superfetation generally does not produce unique or clearly distinguishable symptoms. In most cases, a pregnant woman may not notice anything different from the signs of a typical pregnancy. Symptoms associated with the second conception would largely overlap with those of the first pregnancy, making it difficult to identify the condition based on intuition or symptoms alone.
Although there are no definitive symptoms, a pregnant woman may experience certain general signs, including:
Worsening nausea and vomiting: A pregnant woman may notice an increase in the severity of nausea episodes. However, this is a nonspecific symptom and does not establish the occurrence of superfetation.
Increased fatigue: A general feeling of exhaustion that seems more intense than the usual fatigue associated with pregnancy.
Breast tenderness and swelling: Persistent breast swelling or increased tenderness, neither of which is sufficient to distinguish between the two pregnancies.
Light vaginal spotting: Mild bleeding may occur, but it is not definitive evidence of a newly implanted embryo, as it may be associated with other conditions that require medical evaluation.
Changes in abdominal size or fetal movement: There are no reliable physical signs that can directly confirm the presence of two fetuses conceived at different times.
Important note: These symptoms are general and are not specific to superfetation. A medical diagnosis cannot be made based on symptoms alone.
Clinical symptoms are not sufficient to establish the diagnosis. Medical suspicion primarily relies on repeated ultrasound examinations, with careful comparison of the fetuses' growth patterns and estimated gestational ages. Other, more common explanations for differences in fetal growth must also be ruled out.
If you are pregnant and experience any of the following symptoms, seek urgent medical care, particularly if the pain is severe or progressively worsening:
Severe or persistent abdominal pain, especially when concentrated on one side of the abdomen.
Heavy vaginal bleeding.
Severe dizziness, fainting, or sudden weakness.
Shoulder-tip pain, particularly when accompanied by abdominal pain or vaginal bleeding.
These symptoms may indicate a serious pregnancy complication, including an ectopic pregnancy, and require prompt medical assessment.
Superfetation, also known as becoming pregnant while already pregnant, is evaluated through ultrasound imaging and careful medical follow-up. Other conditions that may produce apparent differences in fetal gestational age must be systematically excluded. Because the phenomenon is exceptionally rare in humans, confirming the diagnosis presents a considerable medical challenge.
Early Transvaginal Ultrasound
Determine the number of embryos and identify their implantation locations.
Measure the crown–rump length (CRL) to estimate the gestational age of each embryo when appropriate.
Compare the estimated gestational ages of the embryos if both are identified.
Serial and Follow-Up Ultrasound Examinations
Repeat ultrasound examinations at intervals determined by the treating physician to monitor the growth of both fetuses.
Assess whether the apparent difference in gestational age persists over time and whether the findings are consistent with different conception dates.
Ruling Out More Common, Similar Conditions
The physician must first consider and exclude other possible explanations, including:
Restricted fetal growth: The smaller fetus may have fetal growth restriction (FGR), also known as intrauterine growth restriction (IUGR).
Errors in gestational age estimation: These may result from an uncertain last menstrual period or variations in the timing of ovulation.
A typical twin pregnancy: Differences in the sizes of twins can occur even when both eggs were fertilized during the same menstrual cycle.
Reviewing Medical Records and Pregnancy History
The physician carefully reviews the date of the last menstrual period, any known ovulation dates, and the use of assisted reproductive technologies when applicable. Previous ultrasound findings are also examined, including the timing of the initial identification of gestational sacs and embryos.
Blood Tests
Measuring the level of beta-human chorionic gonadotropin (beta-hCG) in the blood may provide general information about the pregnancy. However, this test cannot independently diagnose superfetation or accurately distinguish the gestational ages of two fetuses.
Can Superfetation Be Confirmed by Ultrasound Alone?
Not necessarily. Identifying a difference in the estimated gestational ages of two fetuses on ultrasound may raise clinical suspicion, but it does not conclusively prove that fertilization occurred at two different times. A reliable assessment requires longitudinal evaluation of the findings and exclusion of alternative explanations. Consequently, the diagnosis may remain uncertain even in suspected cases.
Superfetation is an exceptionally rare phenomenon, which means that available medical research on its direct complications is limited. Potential risks are generally associated with differences in gestational age between the fetuses, the possibility of premature delivery, and the complications commonly associated with multiple pregnancies.
Preterm Birth: The medical condition of the older, more developmentally advanced fetus may necessitate delivery before the younger fetus has completed its development.
Differences in Fetal Growth: One fetus may be smaller because of a difference in gestational age or due to fetal growth restriction.
Amniotic Fluid Abnormalities: Differences in the amount of amniotic fluid surrounding each fetus may occur, requiring careful monitoring.
Placental Complications: Depending on whether separate placentas develop and how they function, problems affecting placental efficiency or the supply of nutrients to either fetus may arise.
Difficulty Determining the Timing of Delivery: Physicians may face a significant challenge when balancing the risks of continuing the pregnancy against those of delivery, particularly when the fetuses are at different stages of maturity.
Potential risks are often greater for the younger fetus and may include:
Respiratory Distress Syndrome: Due to incomplete lung development.
Low Birth Weight.
Difficulty Regulating Body Temperature.
Low Blood Sugar (Neonatal Hypoglycemia).
The Need for Intensive Care in a Neonatal Intensive Care Unit (NICU).
The severity of these challenges depends primarily on gestational age at birth, each baby's birth weight, and their overall health.
It is important to distinguish between complications directly associated with superfetation and those resulting from premature birth or low birth weight. There is currently no conclusive scientific evidence that superfetation itself causes chronic health problems.
If one of the babies is born extremely prematurely, potential complications may include:
Chronic Respiratory Problems: Particularly in infants who require prolonged mechanical ventilation.
Neurodevelopmental and Motor Delays: Potential difficulties with learning, speech, or movement.
Vision or Hearing Complications: The risk depends on the degree of prematurity and any associated medical conditions.
Feeding and Growth Difficulties: Some infants may require nutritional support and specialized medical follow-up after discharge from the hospital.
Long-Term Developmental Monitoring: Regular assessments may be needed to evaluate physical growth and cognitive and motor development.
These complications are possibilities, not inevitable outcomes. Many children develop normally when they receive appropriate care and medical support.
No chronic diseases have been conclusively established as being directly caused by superfetation itself. However, a multiple pregnancy and preterm delivery may be associated with:
Persistent pregnancy-related symptoms or health issues, depending on their severity.
Psychological Effects: Such as anxiety or postpartum depression, particularly when the babies require admission to intensive care.
Surgical Recovery Challenges: If a cesarean delivery is medically necessary.
Protecting the health of the mother and both fetuses requires careful monitoring and individualized medical management, including the following strategies:
Specialized Care: Close monitoring by a maternal–fetal medicine (MFM) specialist.
Serial Ultrasound Examinations: Repeated ultrasound scans to assess fetal growth, amniotic fluid levels, and placental function.
Careful Fetal Monitoring: Monitoring both fetuses' heart rates and assessing for early signs of preterm labor, as appropriate for their gestational ages.
Individualized Delivery Planning: Determining the most appropriate timing and method of delivery based on the actual medical condition of each fetus, rather than relying solely on differences in gestational age.
Postnatal Assessment: Monitoring the babies' health and development according to their gestational ages at birth and individual medical needs.
What's your complaint?